U.K. Threw Covid Vaccine Maker Under Bus Over Contract, Valneva CEO Says
- Valneva contract termination relates to supply commitments
- U.K. agreement was worth up to $1.6 billion for French biotech
This article is for subscribers only.
The U.K. government threw Valneva SE “under the bus” when it terminated a $1.6 billion Covid-19 vaccine agreement after championing the French drugmaker’s shot, according to its chief executive officer.
The U.K.’s decision to cancel its order over an alleged breach of contract blindsided the company in September and came after Valneva had spent months renegotiating its agreement with Britain’s Vaccines Taskforce, Thomas Lingelbach said in an interview.